What Is An Indirect Elisa How The Two Step Assay Works?

An indirect ELISA is a laboratory test that detects specific antibodies in a blood sample. It works in two main steps: first, an antigen is attached to a plate to capture the target antibody, and second, a labeled secondary antibody binds to the captured antibody to produce a measurable signal. This two-step design is what separates indirect ELISA from other ELISA formats, and it is widely used to diagnose infections and autoimmune conditions.

What Is an Indirect ELISA and How Does the Two-Step Assay Work?

Indirect ELISA detects antibodies, not antigens. When your body fights an infection, it produces antibodies—proteins that bind specifically to the invading pathogen. The indirect ELISA test is designed to catch those antibodies in a blood sample and confirm they are present.

The test begins with a plastic plate, usually with 96 tiny wells. Researchers coat the bottom of each well with a known antigen—a piece of the virus, bacterium, or other substance they want to test against. If your blood contains antibodies to that antigen, they will stick to it during the first incubation step.

After washing away everything that did not bind, the second step begins. A secondary antibody is added. This antibody is designed to bind to human antibodies, and it carries an enzyme or fluorescent tag. If the first step captured any of your antibodies, the secondary antibody attaches to them. A final wash removes unbound secondary antibodies, and a substrate solution is added. The enzyme on the secondary antibody reacts with the substrate to produce a color change. The intensity of that color tells the lab how much antibody is present in your sample.

How Is Indirect ELISA Different from Direct ELISA?

The difference is in the number of antibody layers and what is being detected. Direct ELISA uses one labeled antibody that binds directly to the antigen. Indirect ELISA uses two antibodies: an unlabeled primary antibody that binds the antigen, and a labeled secondary antibody that binds the primary.

That extra layer gives indirect ELISA two practical advantages. First, it amplifies the signal. Several secondary antibodies can bind to a single primary antibody, making the test more sensitive. Second, it is more versatile. The same labeled secondary antibody can be used for many different tests, as long as the primary antibody comes from the same species. This saves time and money in labs that run many different assays.

Direct ELISA is faster because it has fewer steps, but it requires a separate labeled antibody for every target. Indirect ELISA takes longer but offers greater sensitivity and flexibility. For diagnostic purposes, sensitivity matters, which is why indirect ELISA is so common in clinical labs.

What Is Indirect ELISA Used For in Medicine?

Indirect ELISA is one of the most common antibody tests in clinical medicine. It is used to screen for HIV, Lyme disease, hepatitis C, and many other infections. In each case, the test looks for antibodies your immune system made in response to the pathogen.

The test is also central to diagnosing autoimmune diseases. Conditions like rheumatoid arthritis, lupus, and celiac disease involve antibodies that attack your own tissues. Indirect ELISA can detect these autoantibodies and help doctors confirm a diagnosis.

One important limitation is timing. Antibodies take time to develop after an infection. If you are tested too early—during the “window period”—the test can come back negative even though you are infected. This is why doctors sometimes repeat antibody tests weeks later or order a different type of test that detects the pathogen itself.

What Are the Main Steps in Running an Indirect ELISA?

Running an indirect ELISA follows a standardized sequence. Each step is designed to ensure only specific binding produces a signal.

Step 1: Coating. The antigen is applied to the wells of the plate and allowed to adsorb to the plastic surface. This usually takes several hours or overnight.

Step 2: Blocking. A protein solution, often bovine serum albumin, is added to fill any spaces on the plastic that the antigen did not cover. This prevents nonspecific binding later in the test.

Step 3: Primary antibody incubation. The patient’s sample—serum or plasma—is added. If the sample contains antibodies to the coated antigen, they bind. If not, they wash away.

Step 4: Washing. The wells are washed multiple times to remove unbound antibodies and other serum proteins.

Step 5: Secondary antibody incubation. The enzyme-labeled secondary antibody is added. It binds to any human antibodies captured in step 3.

Step 6: Washing again. Another series of washes removes unbound secondary antibody. This step is critical because leftover secondary antibody would produce a false signal.

Step 7: Substrate addition and reading. A substrate solution is added. The enzyme converts it into a colored product. The reaction is stopped after a set time, and a plate reader measures the optical density of each well.

The entire process typically takes two to five hours, depending on incubation times and the specific kit being used.

How Do You Interpret an Indirect ELISA Result?

Results are reported as positive, negative, or indeterminate, but the raw data is numerical. The plate reader measures how much light is absorbed by the colored solution in each well. More color means more enzyme activity, which means more secondary antibody bound, which means more primary antibody was present in the sample.

Each run includes controls. A positive control contains known antibodies and should produce a strong signal. A negative control contains no antibodies and should produce little or no signal. The patient’s result is compared against these controls and against a cutoff value calculated from the assay’s calibration.

A positive result means antibodies were detected. It does not always mean you have an active infection. Antibodies can persist for years after an infection has cleared. For some diseases, a positive antibody test only tells doctors you were exposed at some point. This is why positive screening results are usually confirmed with a more specific test, such as a Western blot or a PCR test that detects the pathogen’s genetic material.

What Are the Limitations and False Results in Indirect ELISA?

Indirect ELISA is sensitive, but it is not perfect. False positives can occur when antibodies in the sample cross-react with the antigen. This happens in some autoimmune diseases, where antibodies meant for one target accidentally bind to another. It also happens after certain vaccinations or infections with related pathogens.

False negatives are usually a timing issue. If the test is run before the immune system has produced enough antibodies, the result will be negative. Most antibody tests require two to eight weeks after exposure to reach reliable sensitivity, though this varies by disease.

Technical errors also cause problems. Incomplete washing leaves background signal that can push a negative sample into the positive range. Poor blocking allows proteins to stick nonspecifically. Contaminated reagents or expired kits produce unreliable results. Clinical labs run strict quality controls to catch these issues, but no test is infallible.

Some research suggests that certain medications or health conditions can affect antibody levels and therefore test results, but the evidence here is limited and varies widely by condition. If you receive an unexpected result, your doctor will likely repeat the test or order a confirmatory assay.

How Does Indirect ELISA Compare to Other Antibody Tests?

Western blot is often used as a confirmatory test after a positive ELISA. It separates proteins by size and detects antibodies against specific protein bands. It is more specific than ELISA but more labor-intensive and expensive.

Rapid lateral flow tests, like home pregnancy tests or rapid COVID-19 antibody tests, use a similar antibody-capture principle but in a simpler format. They give quick results but are generally less sensitive than lab-based ELISA.

Chemiluminescent immunoassays are automated versions of ELISA that use light-producing labels instead of color-producing enzymes. Many large hospital labs use these because they are faster and can process hundreds of samples per hour.

Each method has a role. Indirect ELISA remains a standard because it balances sensitivity, cost, and throughput in a way that works for routine diagnostic screening.